The data generated in our current study not only support the published data that CD11b deficiency can reduce myeloid cell recruitment in tumor environment, but also indicate that CD11b deficiency is likely to inhibit angiogenesis and tumor growth in CRC tumor-bearing mice. Here, ITGAM is linked to colorectal carcinoma.